Wagner et al. [66] and Meißner et al. [76] demonstrated the feasibility of using radiomics features extracted from MR images to predict the BRAF status of pediatric low-grade gliomas and intracranial BRAF-V600E-mutation status in patients with melanoma brain metastases, respectively. This evidence concerns the gene BRAF and central nervous system cancer.